Medicine & Health

Researchers at WashU Medicine have identified central routes that two deadly viruses take to invade human cells and designed “decoy” molecules to block the infections.

When it comes to curbing gun violence in America, the field of public health should consider focusing less on the guns themselves and more on the human emotions that make people reach for guns in the first place, says a researcher from the Brown School at Washington University in St. Louis.

WashU Medicine deans Eva Aagaard, MD, and Nichole Zehnder, MD, have been promoted to assume greater roles leading the Office of Education’s efforts to train the next generation of health and science professionals. Their promotions take effect Nov. 1.

Christopher D. Smyser, MD, a renowned pediatric neurologist specializing in neonatal neurology and infant brain development, has been appointed director of the Division of Pediatric & Developmental Neurology in the Department of Neurology at WashU Medicine.

Researchers at Washington University in St. Louis have created injectable bioelectric hydrogels for use in monitoring biological activity such as heart rate.

In a study published in Nature Neuroscience, researchers at WashU Medicine showed in mice that Alzheimer’s disease upended the daily activity patterns of hundreds of genes in cells that regulate key functions in the brain.

Eva Klinman, MD, PhD, an instructor in the Department of Neurology at WashU Medicine, has been named a 2025 STAT Wunderkind by STAT News for her exceptional contributions to understanding the mechanisms of brain aging and neurodegeneration.

Pamela K. Woodard, MD, head of the Department of Radiology and director of Mallinckrodt Institute of Radiology at WashU Medicine, is among 100 new members elected this year to the National Academy of Medicine, one of the highest honors in health and medicine.

Timothy J. Eberlein, MD, director of Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been active within the American College of Surgeons for many years, including serving as chair of the board from 2022-2023.

With a grant from the Advanced Research Projects Agency for Health, a multi-institutional research team led by scientists at Virginia Tech and Washington University in St. Louis will develop an indoor air device to disrupt transmission of infectious disease.